[Pathophysiology of osteoporosis]

Area of Science:

• Bone biology and skeletal pathology.
• Endocrinology and metabolic bone diseases.
• Gerontology and aging research.

Context:

• Osteoporosis is a complex skeletal condition characterized by reduced bone mass and microarchitectural deterioration, increasing fracture risk.
• Bone mass is determined by peak bone mass acquisition and subsequent bone loss, influenced by numerous interacting factors.
• Imbalances in bone remodeling, specifically between osteoclast-mediated resorption and osteoblast-mediated formation, are central to osteoporosis pathogenesis.

Purpose:

• To elucidate the multifactorial determinants of osteoporosis, encompassing genetic, hormonal, nutritional, and lifestyle influences.
• To highlight the critical role of calcium and phosphate homeostasis and local bone remodeling in maintaining skeletal integrity.
• To establish a pathophysiological basis for developing effective osteoporosis prevention and treatment strategies.

Summary:

• Osteoporosis affects the entire skeleton, marked by low bone mass and compromised microarchitecture, leading to increased fragility.
• Peak bone mass and the rate of bone loss are regulated by genetic, hormonal, nutritional, and lifestyle factors impacting calcium homeostasis and bone remodeling.
• Therapeutic strategies include modifying nutritional deficiencies (calcium, vitamin D), addressing hormonal imbalances (estrogen deficiency), promoting physical activity, and utilizing pharmacologic agents that modulate bone resorption or formation.

Impact:

• Provides a comprehensive understanding of osteoporosis pathophysiology, guiding clinical practice and research.
• Emphasizes the importance of a holistic approach to osteoporosis management, integrating lifestyle modifications with medical interventions.
• Facilitates the design of targeted therapies aimed at restoring bone balance and reducing fracture incidence.